Strengths and limitations of assessing influenza vaccine effectiveness using routinely collected, passive surveillance data in Ontario, Canada, 2007 to 2012: Balancing efficiency versus quality

Eurosurveillance

Volumn 20, Issue 16, 2015, Pages

  Savage, R D ^a,b   Winter, A L ^a   Rosella, L C ^a,b   Olsha, R ^a   Gubbay, J B ^a,c   Skowronski, D M ^d,e   Crowcroft, N S ^a,b,c  

^a PUBLIC HEALTH ONTARIO   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c UNIVERSITY OF TORONTO   (Canada)

^d BRITISH COLUMBIA CENTRE FOR DISEASE CONTROL   (Canada)

^e UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

INFLUENZA VACCINE;

ADOLESCENT; ADULT; AGED; ARTICLE; CANADA; CASE CONTROL STUDY; CHILD; COMORBIDITY; DATA COLLECTION METHOD; DRUG EFFICACY; DRUG SURVEILLANCE PROGRAM; FEMALE; HUMAN; IMMUNIZATION; INFANT; INFLUENZA A (H1N1); INFORMATION PROCESSING; MALE; MIDDLE AGED; SCREENING; SEASONAL VARIATION; TEST NEGATIVE DESIGN STUDY; VACCINE EFFECTIVENESS; VALIDITY; EVALUATION STUDY; HEALTH SURVEY; IMMUNOLOGY; INFLUENZA A VIRUS (H1N1); INFLUENZA, HUMAN; ISOLATION AND PURIFICATION; OUTCOME ASSESSMENT; PANDEMICS; PRESCHOOL CHILD; PROCEDURES; SEASON; VIROLOGY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; CANADA; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; INFANT; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA VACCINES; INFLUENZA, HUMAN; MALE; MIDDLE AGED; OUTCOME ASSESSMENT (HEALTH CARE); PANDEMICS; POPULATION SURVEILLANCE; SEASONS; YOUNG ADULT;

EID: 84928635617     PISSN: 1025496X     EISSN: 15607917     Source Type: Journal    
DOI: 10.2807/1560-7917.ES2015.20.16.21100     Document Type: Article

References (30)

1. Skowronski DM, Gilbert M, Tweed SA, Petric M, Li Y, Mak A, et al. Effectiveness of vaccine against medical consultation due to laboratory-confirmed influenza: results from a sentinel physician pilot project in British Columbia, 2004-2005. Can Commun Dis Rep. 2005; 31(18): 181-91. PMID: 16669132
2. Skowronski DM, Masaro C, Kwindt TL, Mak A, Petric M, Li Y, et al. Estimating vaccine effectiveness against laboratoryconfirmed influenza using a sentinel physician network: results from the 2005-2006 season of dual A and B vaccine mismatch in Canada. Vaccine. 2007; 25(15): 2842-51. Available from: http://dx. doi. org/10. 1016/j. vaccine. 2006. 10. 002 PMID: 17081662
3. Skowronski DM, De Serres G, Dickinson J, Petric M, Mak A, Fonseca K, et al. Component-specific effectiveness of trivalent influenza vaccine as monitored through a sentinel surveillance network in Canada, 2006-2007. J Infect Dis. 2009; 199(2): 168-79. Available from: http://dx. doi. org/10. 1086/595862 PMID: 19086914
4. Janjua NZ, Skowronski DM, De Serres G, Dickinson J, Crowcroft NS, Taylor M, et al. Estimates of influenza vaccine effectiveness for 2007-2008 from Canada's sentinel surveillance system: cross-protection against major and minor variants. J Infect Dis. 2012; 205(12): 1858-68. Available from: http://dx. doi. org/10. 1093/infdis/jis283 PMID: 22492921
5. Skowronski DM, De Serres G, Crowcroft NS, Janjua NZ, Boulianne N, Hottes TS, et al.; Canadian SAVOIR Team. Association between the 2008-09 seasonal influenza vaccine and pandemic H1N1 illness during Spring-Summer 2009: four observational studies from Canada. PLoS Med. 2010; 7(4): e1000258. Available from: http://dx. doi. org/10. 1371/journal. pmed. 1000258 PMID: 20386731
6. Skowronski DM, Janjua NZ, De Serres G, Hottes TS, Dickinson JA, Crowcroft N, et al. Effectiveness of AS03 adjuvanted pandemic H1N1 vaccine: case-control evaluation based on sentinel surveillance system in Canada, autumn 2009. BMJ. 2011; 342(feb03 1): c7297. http://dx. doi. org/10. 1136/bmj. c7297 PMID: 21292718
7. Skowronski DM, Janjua NZ, De Serres G, Winter AL, Dickinson JA, Gardy JL, et al. A sentinel platform to evaluate influenza vaccine effectiveness and new variant circulation, Canada 2010-2011 season. Clin Infect Dis. 2012; 55(3): 332-42. Available from: http://dx. doi. org/10. 1093/cid/cis431 PMID: 22539661
8. Janjua NZ, Skowronski DM, De Serres G, Winter A, Dickinson JA, Mahmud SM, et al. Component-Specific Estimates of 2011-12 Influenza Vaccine Effectiveness Based on the Canadian Sentinel Surveillance System. 10th Canadian Immunization Conference, Vancoouver, BC 3-5 December 2012: P001.
9. Skowronski DM, Janjua NZ, De Serres G, Dickinson JA, Winter AL, Mahmud SM, et al. Interim estimates of influenza vaccine effectiveness in 2012/13 from Canada's sentinel surveillance network, January 2013. Euro Surveill. 2013; 18(5): 20394. PMID: 23399422
10. Orenstein EW, De Serres G, Haber MJ, Shay DK, Bridges CB, Gargiullo P, et al. Methodologic issues regarding the use of three observational study designs to assess influenza vaccine effectiveness. Int J Epidemiol. 2007; 36(3): 623-31. Available from: http://dx. doi. org/10. 1093/ije/dym021 PMID: 17403908
11. De Serres G, Skowronski DM, Wu XW, Ambrose CS. The test-negative design: validity, accuracy and precision of vaccine efficacy estimates compared to the gold standard of randomised placebo-controlled clinical trials. Euro Surveill. 2013; 18(37): 20585. Available from: http://dx. doi. org/10. 2807/1560-7917. ES2013. 18. 37. 20585 PMID: 24079398
12. Frey S, Vesikari T, Szymczakiewicz-Multanowska A, Lattanzi M, Izu A, Groth N, et al. Clinical efficacy of cell culture-derived and egg-derived inactivated subunit influenza vaccines in healthy adults. Clin Infect Dis. 2010; 51(9): 997-1004. Available from: http://dx. doi. org/10. 1086/656578 PMID: 20868284
13. Monto AS, Ohmit SE, Petrie JG, Johnson E, Truscon R, Teich E, et al. Comparative efficacy of inactivated and live attenuated influenza vaccines. N Engl J Med. 2009; 361(13): 1260-7. Available from: http://dx. doi. org/10. 1056/NEJMoa0808652 PMID: 19776407
14. Fleming DM, Andrews NJ, Ellis JS, Bermingham A, Sebastianpillai P, Elliot AJ, et al. Estimating influenza vaccine effectiveness using routinely collected laboratory data. J Epidemiol Community Health. 2010; 64(12): 1062-7. Available from: http://dx. doi. org/10. 1136/jech. 2009. 093450 PMID: 19910645
15. Farrington CP. Estimation of vaccine effectiveness using the screening method. Int J Epidemiol. 1993; 22(4): 742-6. http://dx. doi. org/10. 1093/ije/22. 4. 742 PMID: 8225751
16. Valenciano M, Kissling E, Ciancio BC, Moren A. Study designs for timely estimation of influenza vaccine effectiveness using European sentinel practitioner networks. Vaccine. 2010; 28(46): 7381-8. Available from: http://dx. doi. org/10. 1016/j. vaccine. 2010. 09. 010 PMID: 20851086
17. Ontario Ministry of Health and Long-Term Care. Influenza Vaccine Fact Sheet. Toronto: Queen's Printer for Ontario. [Accessed: 20 Apr 2015]. Available from: http://www. health. gov. on. ca/en/pro/programs/publichealth/flu/uiip/uiip_flu_fact_sheet. pdf
18. National Advisory Committee on Immunization. Statement on Seasonal Influenza Vaccine for 2013-2014. Canada Communicable Disease Report. 2013; 39. Available from: http://www. phac-aspc. gc. ca/publicat/ccdr-rmtc/13vol39/acs-dcc-4/index-eng. php
19. Influenza and other respiratory viral testing for the 2013-2014 influenza season (November 4, 2013 to May 5, 2014). Labstract-November 2013; Toronto: Public Health Ontario. [Accessed: 29 Jan 2014]. Available from: http://www. publichealthontario. ca/en/eRepository/LAB_SD_070_Influenza_respiratory_viral_testing_2013-14_season. pdf
20. Statistics Canada. Canadian community health survey-annual component (CCHS). Ottawa: Queen's Printer for Canada. [Accessed: 19 Nov 2013]. Available from: http://www23. statcan. gc. ca/imdb/p2SV. pl?Function=getSurvey&SDDS=3226 &Item_Id=118913
21. Moran K, Maaten S, Guttmann A, Northrup D, Kwong JC. Influenza vaccination rates in Ontario children: implications for universal childhood vaccination policy. Vaccine. 2009; 27(17): 2350-5. Available from: http://dx. doi. org/10. 1016/j. vaccine. 2009. 02. 017 PMID: 19428850
22. Seyler T, Bella A, Puzelli S, Donatelli I, Rizzo C. Screening method working group. Estimating pandemic vaccine effectiveness in two Italian regions using the screening method, 2009-2010. Vaccine. 2012; 30(2): 109-11. Available from: http://dx. doi. org/10. 1016/j. vaccine. 2011. 11. 013 PMID: 22100893
23. Ontario Agency for Health Protection and Promotion Act. SO 2007, c 10. Toronto: Queen's Printer for Ontario. [Accessed: 20 Apr 2015]. Available from: http://www. ontario. ca/laws/statute/07o10
24. Osterholm MT, Kelley NS, Sommer A, Belongia EA. Efficacy and effectiveness of influenza vaccines: a systematic review and meta-analysis. Lancet Infect Dis. 2012; 12(1): 36-44. Available from: http://dx. doi. org/10. 1016/S1473-3099(11)70295-X PMID: 22032844
25. Ohmit SE, Petrie JG, Malosh RE, Cowling BJ, Thompson MG, Shay DK, et al. Influenza vaccine effectiveness in the community and the household. Clin Infect Dis. 2013; 56(10): 1363-9. Available from: http://dx. doi. org/10. 1093/cid/cit060 PMID: 23413420
26. Weinberg GA, Erdman DD, Edwards KM, Hall CB, Walker FJ, Griffin MR, et al. Superiority of reverse-transcription polymerase chain reaction to conventional viral culture in the diagnosis of acute respiratory tract infections in children. J Infect Dis. 2004; 189(4): 706-10. Available from: http://dx. doi. org/10. 1086/381456 PMID: 14767825
27. Ontario Ministry of Health and Long-Term Care. Infectious disease protocol, 2013: Appendix A: Disease-specific chapters (Influenza). Toronto; Queen's Printer for Ontario; 2009. Available from: http://www. health. gov. on. ca/en/pro/programs/publichealth/oph_standards/docs/influenza_chapter. pdf
28. Skowronski D, Chambers C, Sabaiduc S, De Serres G, Dickinson J, Winter A, et al. Interim estimates of 2013/14 vaccine effectiveness against influenza A(H1N1)pdm09 from Canada s sentinel surveillance network, January 2014. Euro Surveill. 2014; 19(5): 20690. Available from: http://dx. doi. org/10. 2807/1560-7917. ES2014. 19. 5. 20690 PMID: 24524234
29. Kwong JC, Campitelli MA, Gubbay JB, Peci A, Winter AL, Olsha R, et al. Vaccine effectiveness against laboratory-confirmed influenza hospitalizations among elderly adults during the 2010-2011 season. Clin Infect Dis. 2013; 57(6): 820-7. Available from: http://dx. doi. org/10. 1093/cid/cit404 PMID: 23788243
30. Kwong JC, Manuel DG. Using OHIP physician billing claims to ascertain individual influenza vaccination status. Vaccine. 2007; 25(7): 1270-4. Available from: http://dx. doi. org/10. 1016/j. vaccine. 2006. 10. 004 PMID: 17079057